On Wednesday, June 8, the House of Representatives voted to approve the Pre-approval Information Exchange Act as part of the Food & Drug Amendments of 2022 to reauthorize the FDA User Fee Agreements.

AMCP is pleased to be recognized by the Office of Disease Prevention and Health Promotion within the U.S. Department of Health and Human Services as a Healthy People 2030 Champion.

Last week, nearly 40 experts and key stakeholders in the managed care setting convened for AMCP’s Partnership Forum: High-Investment Medications.

AMCP Foundation announces Best Poster recipients during AMCP 2022. This semiannual competition culminates twice per year at AMCP national meetings, with awards for new practitioners presented in three categories.

During AMCP Foundation's 2022 National P&T Competition, the University of Michigan received the first place prize. The competition convened student pharmacists from around the country to develop a formulary drug monograph, considering evidence gaps; value; health equity; and utilization management tools.

Mason Johnson, BS, PharmD candidate, will serve as the 2022-2023 Executive Fellow in Health Care Association Leadership. His fellowship will begin July 1, 2022.

AMCP applauds Senators Moore Capito (R-WV) and Shaheen (D-NH) and Congressmen Thompson (D-CA-5) and McKinley (R-WV-1) on the introduction of the bipartisan Access to Prescription Digital Therapeutics Act.